Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 24223052)

1.

Adherence to psychostimulant medication in children with attention-deficit/hyperactivity disorder: the role of attitudes.

Hébert J, Polotskaia A, Joober R, Grizenko N.

J Can Acad Child Adolesc Psychiatry. 2013 Nov;22(4):317-23.

2.

Attention deficit hyperactivity disorder: anxiety phenomena in children treated with psychostimulant medication for 6 months or more.

Vance AL, Luk ES, Costin J, Tonge BJ, Pantelis C.

Aust N Z J Psychiatry. 1999 Jun;33(3):399-406.

PMID:
10442797
3.
4.
5.
6.

The meaning of attention-deficit/hyperactivity disorder medication and parents' initiation and continuity of treatment for their child.

DosReis S, Mychailyszyn MP, Evans-Lacko SE, Beltran A, Riley AW, Myers MA.

J Child Adolesc Psychopharmacol. 2009 Aug;19(4):377-83. doi: 10.1089/cap.2008.0118.

8.

Treatment experiences of children and adolescents with attention-deficit/hyperactivity disorder.

Leggett C, Hotham E.

J Paediatr Child Health. 2011 Aug;47(8):512-7. doi: 10.1111/j.1440-1754.2011.02013.x.

PMID:
21843188
9.

Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment.

Pappadopulos E, Jensen PS, Chait AR, Arnold LE, Swanson JM, Greenhill LL, Hechtman L, Chuang S, Wells KC, Pelham W, Cooper T, Elliott G, Newcorn JH.

J Am Acad Child Adolesc Psychiatry. 2009 May;48(5):501-10. doi: 10.1097/CHI.0b013e31819c23ed.

PMID:
19307987
10.

Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.

Zwi M, Jones H, Thorgaard C, York A, Dennis JA.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Review.

PMID:
22161373
11.

The attention-deficit/hyperactivity disorder medication-related attitudes of patients and their parents.

Harpur RA, Thompson M, Daley D, Abikoff H, Sonuga-Barke EJ.

J Child Adolesc Psychopharmacol. 2008 Oct;18(5):461-73. doi: 10.1089/cap.2008.023.

PMID:
18928411
12.

Parent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorder.

Coletti DJ, Pappadopulos E, Katsiotas NJ, Berest A, Jensen PS, Kafantaris V.

J Child Adolesc Psychopharmacol. 2012 Jun;22(3):226-37. doi: 10.1089/cap.2011.0090. Epub 2012 Apr 26.

13.

A preliminary study of factors affecting adherence to medication in clinic children with attention-deficit/hyperactivity disorder.

Sitholey P, Agarwal V, Chamoli S.

Indian J Psychiatry. 2011 Jan;53(1):41-4. doi: 10.4103/0019-5545.75561.

14.

Assessment of parents' preferences for the treatment of school-age children with ADHD: a discrete choice experiment.

Fegert JM, Slawik L, Wermelskirchen D, Nübling M, Mühlbacher A.

Expert Rev Pharmacoecon Outcomes Res. 2011 Jun;11(3):245-52. doi: 10.1586/erp.11.22. Review.

PMID:
21671692
15.

Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory.

Barnett R, Maruff P, Vance A, Luk ES, Costin J, Wood C, Pantelis C.

Psychol Med. 2001 Aug;31(6):1107-15.

PMID:
11513378
16.

Improving psychostimulant adherence in children with ADHD.

Charach A, Gajaria A.

Expert Rev Neurother. 2008 Oct;8(10):1563-71. doi: 10.1586/14737175.8.10.1563. Review.

PMID:
18928348
17.

Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD.

Thiruchelvam D, Charach A, Schachar RJ.

J Am Acad Child Adolesc Psychiatry. 2001 Aug;40(8):922-8.

PMID:
11501692
18.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk